Bank of New York Mellon
TRAW icon

Bank of New York Mellon’s Traws Pharma TRAW Stock Holding History

Bank of New York Mellon’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-300
Closed -$112K – 4481
2021
Q1 		$112K Buy
300
+197
+191% +$74.3K ﹤0.01% 4150
2020
Q4 		$18K Hold
103
– – ﹤0.01% 4194
2020
Q3 		$11K Buy
+103
New +$25.5K ﹤0.01% 4103
2014
Q2 		– Hold
0
– -$102K – 4275
2014
Q1 		– Hold
0
– – – 3983
2013
Q4 		– Hold
0
– – – 3869
2013
Q3 		– Hold
0
– – – 3594

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Bank of New York Mellon's TRAW Position: Q2 2021 in Review

Bank of New York Mellon sold out of Traws Pharma (TRAW) in Q2 2021, closing a stake of 300 shares — an estimated $112K sold.

Bank of New York Mellon first reported a position in TRAW in Q3 2020 and held it in 3 quarters. The position peaked at $112K in Q1 2021. 25 funds tracked by Wall St. Rank hold TRAW as of Q2 2021.

  • Bank of New York Mellon reported no remaining Traws Pharma position as of Q2 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 300 Traws Pharma shares in Q2 2021, an estimated $112K.
  • Bank of New York Mellon first reported a position in Traws Pharma in Q3 2020 and held it in 3 quarters.
  • Bank of New York Mellon's Traws Pharma position peaked at $112K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2021.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.